Pentagastrin infusions in patients with panic disorder II. Neuroendocrinology (Q48089410)

8 February 2018

reason for preferred rank

title

Pentagastrin infusions in patients with panic disorder II. Neuroendocrinology (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

17 May 2024

Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524696

17 May 2024

1 reference

1

Abelson JL

1 reference

8 February 2018

author name string

R. M. Nesse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524696

17 May 2024

A. I. Vinik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524696

17 May 2024

language of work or name

English

0 references

publication date

1 July 1994

1 reference

8 February 2018

15 July 1994

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7524696

full work available at URL

17 May 2024

http://deepblue.lib.umich.edu/bitstream/2027.42/31438/1/0000356.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524696

https://api.elsevier.com/content/article/PII:0006322394911886?httpAccept=text/xml

17 May 2024

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

https://api.elsevier.com/content/article/PII:0006322394911886?httpAccept=text/plain

17 May 2024

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

17 May 2024

published in

Biological Psychiatry

1 reference

8 February 2018

volume

36

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

84-96

1 reference

8 February 2018

Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder

17 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder

17 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin

17 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Stress Hormones: Their Interaction and Regulation

17 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

The role of CCK caerulein, and CCK antagonists in nociception

17 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Human corticotropin releasing hormone: clinical studies in patients with affective disorders, alcoholism, panic disorder and in normal controls

17 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Cholecystokinin modulation of [3H]noradrenaline release from superfused hypothalamic slices

17 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

17 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Lymphocyte cholecystokinin concentrations in panic disorder

17 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological function

17 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers

17 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Increased levels of substance P and cholecystokinin in rat cerebral cortex following repeated electroconvulsive shock and subchronic treatment with a serotonin uptake inhibitor

17 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.

17 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Platelet alpha-2-receptor binding and adenylate cyclase activity in panic disorder

17 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Cholecystokinin-dopamine interactions

17 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Serum Cortisol Response to Incremental Work in Experienced and Naive Subjects

17 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings

17 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Effect of Pentagastrin on Adrenocorticotropin Hormone and Thyroid-Stimulating Hormone Release in Normal Subjects

17 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Cholecystokinin antagonists--a toxicologic perspective

17 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Short-term catecholamine response to psychological stress

17 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders

17 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

The hypothalamic-pituitary-adrenal system in panic disorder

17 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Hypothalamic-pituitary-adrenocortical activity in panic disorder: Relationship to plasma catecholamine metabolites

17 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Neurochemical actions of CCK underlying the therapeutic potential of CCK-B antagonists

17 May 2024

27

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Action of peripherally administered cholecystokinin on monoaminergic and GABAergic neurons in the rat brain

17 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Suppressive effects of cholecystokinin and bombesin on growth hormone and prolactin secretion in urethane-anesthetized rats.

17 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Cholecystokinin and satiation with alcohol

17 May 2024

30

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Pituitary Gastrins Occur in Corticotrophs and Melanotrophs

17 May 2024

31

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

In vivo and in vitro Effects of Cholecystokinin Octapeptide on the Release of β-Endorphin-Like Immunoreactivity

17 May 2024

32

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

In Vivo and In Vitro Effects of Cholecystokinin Octapeptide on the Release of Growth Hormone in Rats

17 May 2024

33

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Role of cholecystokinin in corticotropin release: coexistence with vasopressin and corticotropin-releasing factor in cells of the rat hypothalamic paraventricular nucleus

17 May 2024

34

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man

17 May 2024

35

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Adrenergic function in patients with panic anxiety

17 May 2024

36

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome

17 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA.

17 May 2024

38

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treated schizophrenic patients

17 May 2024

39

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Localisation of gastrins to neuro- and adenohypophysis

17 May 2024

40

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Neuronal cholecystokinin: one or multiple transmitters?

17 May 2024

41

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Pituitary tumors containing cholecystokinin

17 May 2024

43

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Neuroendocrine significance of vasoactive intestinal polypeptide

17 May 2024

44

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Cholecystokinin-8 stimulates adrenocorticotropin release from anterior pituitary cells

17 May 2024

45

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Influence of the Frequency of Ovine Corticotropin- Releasing Factor Administration on Adrenocorticotropin and Corticosterone Secretion in the Rat*

17 May 2024

46

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat

17 May 2024

47

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Stress test reactivity in panic disorder

17 May 2024

48

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

The corticotropin-releasing hormone stimulation test in patients with panic disorder

17 May 2024

49

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Facilitation of GABA release by cholecystokinin and caerulein in rat cerebral cortex

17 May 2024

50

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Substance P opens cation channels and closes potassium channels in rat locus coeruleus neurons

17 May 2024

51

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Role of CCK in regulation of food intake

17 May 2024

52

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

17 May 2024

53

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

The corticotropin-releasing hormone test in patients with posttraumatic stress disorder

17 May 2024

54

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Neuroendocrine regulation of growth hormone secretion in sheep. IV. Central and peripheral cholecystokinin

17 May 2024

56

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat

17 May 2024

59

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Co-existence of cholecystokinin- or gastrin-like peptides with other peptides in the hypophysis and the hypothalamus

17 May 2024

61

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Plasma Substance-P in Neuroendocrine Tumors and Idiopathic Flushing: The Value of Pentagastrin Stimulation Tests and the Effects of Somatostatin Analog*

17 May 2024

62

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Hormonal responses to exhausting physical exercise: the role of predictability and controllability of the situation.

17 May 2024

63

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Influence of Human Corticotropin-Releasing Hormone and Adrenocorticotropin upon Spontaneous Growth Hormone Secretion

17 May 2024

64

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Cholecystokinin antagonists

17 May 2024

65

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Functional role of brain CCK receptors

17 May 2024

66

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Corticotropin-releasing factor stimulation of adrenocorticotropin and beta-endorphin release: effects of acute and chronic stress

17 May 2024

67

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies

17 May 2024

68

1 reference

https://api.crossref.org/works/10.1016/0006-3223(94)91188-6

17 May 2024

Identifiers

1 reference

8 February 2018

1 reference

8 February 2018